vs
Side-by-side financial comparison of Ovintiv Inc. (OVV) and SELECT MEDICAL HOLDINGS CORP (SEM). Click either name above to swap in a different company.
Ovintiv Inc. is the larger business by last-quarter revenue ($2.1B vs $1.4B, roughly 1.5× SELECT MEDICAL HOLDINGS CORP). Ovintiv Inc. runs the higher net margin — 46.1% vs 1.4%, a 44.6% gap on every dollar of revenue. On growth, SELECT MEDICAL HOLDINGS CORP posted the faster year-over-year revenue change (6.4% vs -6.0%). Ovintiv Inc. produced more free cash flow last quarter ($489.0M vs $5.2M). Over the past eight quarters, SELECT MEDICAL HOLDINGS CORP's revenue compounded faster (2.8% CAGR vs -7.2%).
Ovintiv Inc. is a U.S. petroleum company based in Denver. The company was formed in 2020 through a restructuring of its Canadian predecessor, Encana.
Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange.
OVV vs SEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.1B | $1.4B |
| Net Profit | $946.0M | $20.2M |
| Gross Margin | — | — |
| Operating Margin | 21.2% | 4.6% |
| Net Margin | 46.1% | 1.4% |
| Revenue YoY | -6.0% | 6.4% |
| Net Profit YoY | 1676.7% | 225.7% |
| EPS (diluted) | $3.64 | $0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.1B | $1.4B | ||
| Q3 25 | $2.0B | $1.4B | ||
| Q2 25 | $2.2B | $1.3B | ||
| Q1 25 | $2.4B | $1.4B | ||
| Q4 24 | $2.2B | $1.3B | ||
| Q3 24 | $2.2B | $1.3B | ||
| Q2 24 | $2.2B | $1.3B | ||
| Q1 24 | $2.4B | $1.3B |
| Q4 25 | $946.0M | $20.2M | ||
| Q3 25 | $148.0M | $28.8M | ||
| Q2 25 | $307.0M | $40.6M | ||
| Q1 25 | $-159.0M | $56.7M | ||
| Q4 24 | $-60.0M | $-16.1M | ||
| Q3 24 | $507.0M | $55.6M | ||
| Q2 24 | $340.0M | $77.6M | ||
| Q1 24 | $338.0M | $96.9M |
| Q4 25 | 21.2% | 4.6% | ||
| Q3 25 | 13.5% | 5.4% | ||
| Q2 25 | 23.1% | 6.5% | ||
| Q1 25 | -3.7% | 8.3% | ||
| Q4 24 | 0.1% | 1.6% | ||
| Q3 24 | 24.2% | 4.3% | ||
| Q2 24 | 25.4% | 5.8% | ||
| Q1 24 | 20.7% | 9.0% |
| Q4 25 | 46.1% | 1.4% | ||
| Q3 25 | 7.3% | 2.1% | ||
| Q2 25 | 13.9% | 3.0% | ||
| Q1 25 | -6.7% | 4.2% | ||
| Q4 24 | -2.7% | -1.2% | ||
| Q3 24 | 23.3% | 4.4% | ||
| Q2 24 | 15.5% | 6.1% | ||
| Q1 24 | 14.2% | 7.3% |
| Q4 25 | $3.64 | $0.17 | ||
| Q3 25 | $0.57 | $0.23 | ||
| Q2 25 | $1.18 | $0.32 | ||
| Q1 25 | $-0.61 | $0.44 | ||
| Q4 24 | $-0.22 | $-0.12 | ||
| Q3 24 | $1.92 | $0.43 | ||
| Q2 24 | $1.27 | $0.60 | ||
| Q1 24 | $1.24 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $280.0M | $26.5M |
| Total DebtLower is stronger | $5.2B | $1.8B |
| Stockholders' EquityBook value | $11.2B | $1.7B |
| Total Assets | $20.4B | $5.9B |
| Debt / EquityLower = less leverage | 0.46× | 1.06× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $280.0M | $26.5M | ||
| Q3 25 | $25.0M | $60.1M | ||
| Q2 25 | $20.0M | $52.3M | ||
| Q1 25 | $8.0M | $53.2M | ||
| Q4 24 | $42.0M | $59.7M | ||
| Q3 24 | $9.0M | $191.5M | ||
| Q2 24 | $8.0M | $111.2M | ||
| Q1 24 | $5.0M | $92.6M |
| Q4 25 | $5.2B | $1.8B | ||
| Q3 25 | $5.2B | $1.7B | ||
| Q2 25 | $5.3B | $1.8B | ||
| Q1 25 | $5.5B | $1.8B | ||
| Q4 24 | $5.5B | $1.7B | ||
| Q3 24 | $5.9B | $3.1B | ||
| Q2 24 | $6.1B | $3.6B | ||
| Q1 24 | $6.2B | $3.8B |
| Q4 25 | $11.2B | $1.7B | ||
| Q3 25 | $10.2B | $1.7B | ||
| Q2 25 | $10.4B | $1.7B | ||
| Q1 25 | $10.1B | $1.7B | ||
| Q4 24 | $10.3B | $1.7B | ||
| Q3 24 | $10.7B | $1.9B | ||
| Q2 24 | $10.3B | $1.4B | ||
| Q1 24 | $10.3B | $1.4B |
| Q4 25 | $20.4B | $5.9B | ||
| Q3 25 | $19.4B | $5.7B | ||
| Q2 25 | $19.7B | $5.7B | ||
| Q1 25 | $19.6B | $5.7B | ||
| Q4 24 | $19.3B | $5.6B | ||
| Q3 24 | $19.9B | $8.0B | ||
| Q2 24 | $19.8B | $7.9B | ||
| Q1 24 | $19.8B | $7.9B |
| Q4 25 | 0.46× | 1.06× | ||
| Q3 25 | 0.51× | 1.03× | ||
| Q2 25 | 0.51× | 1.10× | ||
| Q1 25 | 0.55× | 1.03× | ||
| Q4 24 | 0.53× | 1.01× | ||
| Q3 24 | 0.55× | 1.62× | ||
| Q2 24 | 0.59× | 2.54× | ||
| Q1 24 | 0.60× | 2.75× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $954.0M | $64.3M |
| Free Cash FlowOCF − Capex | $489.0M | $5.2M |
| FCF MarginFCF / Revenue | 23.8% | 0.4% |
| Capex IntensityCapex / Revenue | 22.6% | 4.2% |
| Cash ConversionOCF / Net Profit | 1.01× | 3.19× |
| TTM Free Cash FlowTrailing 4 quarters | $1.5B | $117.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $954.0M | $64.3M | ||
| Q3 25 | $812.0M | $175.3M | ||
| Q2 25 | $1.0B | $110.3M | ||
| Q1 25 | $873.0M | $-3.5M | ||
| Q4 24 | $1.0B | $125.4M | ||
| Q3 24 | $1.0B | $181.0M | ||
| Q2 24 | $1.0B | $278.2M | ||
| Q1 24 | $659.0M | $-66.7M |
| Q4 25 | $489.0M | $5.2M | ||
| Q3 25 | $268.0M | $122.2M | ||
| Q2 25 | $492.0M | $45.6M | ||
| Q1 25 | $256.0M | $-55.8M | ||
| Q4 24 | $468.0M | $62.0M | ||
| Q3 24 | $484.0M | $130.3M | ||
| Q2 24 | $398.0M | $222.6M | ||
| Q1 24 | $68.0M | $-119.2M |
| Q4 25 | 23.8% | 0.4% | ||
| Q3 25 | 13.3% | 9.0% | ||
| Q2 25 | 22.2% | 3.4% | ||
| Q1 25 | 10.8% | -4.1% | ||
| Q4 24 | 21.4% | 4.7% | ||
| Q3 24 | 22.2% | 10.2% | ||
| Q2 24 | 18.1% | 17.4% | ||
| Q1 24 | 2.8% | -9.0% |
| Q4 25 | 22.6% | 4.2% | ||
| Q3 25 | 26.9% | 3.9% | ||
| Q2 25 | 23.5% | 4.8% | ||
| Q1 25 | 26.0% | 3.9% | ||
| Q4 24 | 25.3% | 4.8% | ||
| Q3 24 | 24.7% | 4.0% | ||
| Q2 24 | 28.4% | 4.3% | ||
| Q1 24 | 24.8% | 4.0% |
| Q4 25 | 1.01× | 3.19× | ||
| Q3 25 | 5.49× | 6.09× | ||
| Q2 25 | 3.30× | 2.72× | ||
| Q1 25 | — | -0.06× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.02× | 3.25× | ||
| Q2 24 | 3.00× | 3.59× | ||
| Q1 24 | 1.95× | -0.69× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OVV
| Product And Service Revenue | $1.7B | 84% |
| Sales Of Purchased Product | $338.0M | 16% |
SEM
| Critical Illness Recovery Hospitals | $629.7M | 45% |
| Health Care Patient Service Non Medicare | $428.6M | 31% |
| Rehabilitation Hospitals | $339.2M | 24% |
